Brief: Coloplast Q3 Adjusted EBIT DKK 1,870 Million Vs. Estimate DKK 1,896 Million
20/08/2024 06:34
Aug 20 (Reuters) - Coloplast Q3 EBIT DKK 1,870 million. * Q3 EBIT margin 27% * Q3 revenue DKK 6,885 million vs. estimate DKK 6,800 million * Q3 net income DKK 1,274 million vs. estimate DKK 1,354 million * Q3 pretax profit DKK 1,631 million * outlook FY organic growth 8%
Recent news on Coloplast A/S
See all newsMorgan Stanley sees selective medtech opportunities on growth recovery
Brief: Coloplast’s Inflatable Penile Prosthesis Approved By FDA
Denmark's Coloplast Q2 organic revenue rises 6% on urology momentum
Brief: Coloplast Books DKK 3 Bln Impairment In H1
Brief: Coloplast Receives Innovative Technology Contract From Vizient For Biatain® Silicone Fit